相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study
Alfredo Caturano et al.
BIOMEDICINES (2023)
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies
Erica Vetrano et al.
BIOMEDICINES (2023)
Apolipoprotein F concentration, activity, and the properties of LDL controlling ApoF activation in hyperlipidemic plasma
Richard E. Morton et al.
JOURNAL OF LIPID RESEARCH (2022)
RNA-binding proteins and their role in kidney disease
Lisa Seufert et al.
NATURE REVIEWS NEPHROLOGY (2022)
Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors
Sven Francque et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Non-alcoholic fatty liver disease
Elizabeth E. Powell et al.
LANCET (2021)
The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments
Giovanni Targher et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Epigenetics in NAFLD/NASH: Targets and therapy
Nalini Sodum et al.
PHARMACOLOGICAL RESEARCH (2021)
Transcriptomics Identify Thrombospondin-2 as a Biomarker for NASH and Advanced Liver Fibrosis
Kazuhiro Kozumi et al.
HEPATOLOGY (2021)
Current treatment paradigms and emerging therapies for NAFLD/NASH
Sana Raza et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2021)
Identification of transcriptomic signatures and crucial pathways involved in non-alcoholic steatohepatitis
Weiwei He et al.
ENDOCRINE (2021)
Identification of a hormone response element that mediates suppression of APOF by LXR and PPARα agonists
Yan Liu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2020)
Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD
James M. Paik et al.
HEPATOLOGY (2020)
The nonalcoholic fatty liver disease-like phenotype and lowered serum VLDL are associated with decreased expression and DNA hypermethylation of hepatic ApoB in male offspring of ApoE deficient mothers fed a with Western diet
Hsiao-Chien Chen et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2020)
The Relevance of Thimet Oligopeptidase in the Regulation of Energy Metabolism and Diet-Induced Obesity
Mayara C. F. Gewehr et al.
BIOMOLECULES (2020)
Bioinformatics combined with quantitative proteomics analyses and identification of potential biomarkers in cholangiocarcinoma
Zijian Da et al.
CANCER CELL INTERNATIONAL (2020)
Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease
Ze Chen et al.
FREE RADICAL BIOLOGY AND MEDICINE (2020)
NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications
Giovanni Targher et al.
GUT (2020)
Nonalcoholic Steatohepatitis: A Review
Adam C. Sheka et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
miR-101-3p and miR-199b-5p promote cell apoptosis in oral cancer by targeting BICC1
Hong Wang et al.
MOLECULAR AND CELLULAR PROBES (2020)
Noninvasive Diagnosis of NAFLD and NASH
Valeria Annarita Piazzolla et al.
CELLS (2020)
Apolipoprotein F: a natural inhibitor of cholesteryl ester transfer protein and a key regulator of lipoprotein metabolism
Yan Liu et al.
CURRENT OPINION IN LIPIDOLOGY (2020)
Hepatitis C virus infection and tight junction proteins: The ties that bind
Laurent Mailly et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2020)
Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease
Anne Fougerat et al.
CELLS (2020)
The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease
Nikolaos Perakakis et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates
Rulin Zhao et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Thimet Oligopeptidase Biochemical and Biological Significances: Past, Present, and Future Directions
Emer S. Ferro et al.
BIOMOLECULES (2020)
E. coli NF73-1 Isolated From NASH Patients Aggravates NAFLD in Mice by Translocating Into the Liver and Stimulating M1 Polarization
Yifan Zhang et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
DNA Methylation in Nonalcoholic Fatty Liver Disease
Jeongeun Hyun et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Gut Dysfunction and Non-alcoholic Fatty Liver Disease
Felix Grabherr et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease
Laurent Castera et al.
GASTROENTEROLOGY (2019)
The Circulating Micro-RNAs (-122,-34a and-99a) as Predictive Biomarkers for Non-Alcoholic Fatty Liver Diseases
Olfat M. Hendy et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2019)
DNA methylation-driven genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma
Junyu Long et al.
THERANOSTICS (2019)
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman et al.
NATURE MEDICINE (2018)
Triggering and resolution of inflammation in NASH
Susanne Schuster et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Beneficial effects of naringenin in liver diseases: Molecular mechanisms
Erika Hernandez-Aquino et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Altered DNA Methylation Sites in Peripheral Blood Leukocytes from Patients with Simple Steatosis and Nonalcoholic Steatohepatitis (NASH)
Jiayu Wu et al.
MEDICAL SCIENCE MONITOR (2018)
Absolute quantitation of disease protein biomarkers in a single LC-MS acquisition using apolipoprotein F as an example
Abhinav Kumar et al.
SCIENTIFIC REPORTS (2017)
Metabonomics screening of serum identifies pyroglutamate as a diagnostic biomarker for nonalcoholic steatohepatitis
Suwen Qi et al.
CLINICA CHIMICA ACTA (2017)
Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease
Rohit Loomba et al.
CELL METABOLISM (2017)
Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Gregory Thomas Brown et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Tight junctions: from simple barriers to multifunctional molecular gates
Ceniz Zihni et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
Modeling the mechanisms of biological GTP hydrolysis
Alexandra T. P. Carvalho et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2015)
Hepatic Injury in Nonalcoholic Steatohepatitis Contributes to Altered Intestinal Permeability
Jay Luther et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2015)
Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease
Kenneth Cusi et al.
JOURNAL OF HEPATOLOGY (2014)
DNA Methylation Analysis in Nonalcoholic Fatty Liver Disease Suggests Distinct Disease-Specific and Remodeling Signatures after Bariatric Surgery
Markus Ahrens et al.
CELL METABOLISM (2013)
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Peter A. Jones
NATURE REVIEWS GENETICS (2012)
分享论文
